Before the coronavirus disease 2019 (COVID-19) pandemic, a transgender woman was scheduled for gender-affirming surgery (GAS) in the form of facial feminization surgery (FFS), including rhinoplasty, frontal sinus reduction, and laryngeal chondroplasty. In response to the international medical crisis, a shelter-in-place order was implemented, and her surgeon was mandated to postpone elective surgical procedures indefinitely. Now, the shelter-in-place order has expired, and surgeons around the globe are preparing for transition back toward more widespread health care delivery. The patient's surgeon has begun performing medically necessary, nonurgent procedures. The surgeon's hospital has a low COVID-19 census, has adequate personal protective equipment (PPE), and is testing all preoperative patients for COVID-19. The patient calls to inquire about her FFS. She is informed that GAS was recently categorized as ''routine priority'' by professional guidelines and therefore will be rescheduled later. She disagrees with this determination, arguing that FFS should be prioritized over other elective procedures due to severe gender dysphoria (GD) and its effects on her overall health. She is also concerned her insurance authorization for the procedures will be jeopardized. This case is hypothetical. Point: It is reasonable to deprioritize GAS procedures during the COVID-19 pandemic. GAS procedures are an important part of genderaffirming care (GAC) but do not in themselves represent a cure for GD or guarantee symptomatic relief. GD, the psychological distress that results from incongruence between gender identity and natally assigned gender, causes clinically significant impairment in social, occupational, and other important areas of functioning. 1 Furthermore, the stigma and